Sunday, December 21, 2025
HomeFeatured

Featured

Featured posts

Pharma

J&J single-shot Covid-19 vaccine shows 66% efficacy overall

Life Sciences Times - 0
Biotech

Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK

Life Sciences Times - 0
Pharma

200 million extra doses: Biden-led Covid-19 turnaround kicks off

Life Sciences Times - 0
Real Estate

Life Sciences Firm Oncorus Leases 88,184-SF in Andover, MA

Life Sciences Times - 0
Public Health

Mexican President tests positive for Covid-19

Life Sciences Times - 0
Pharma

Moderna says its Covid-19 vaccine works against new variants

Life Sciences Times - 0
Pharma

Australia gives provisional approval to Pfizer Covid-19 vaccine

Life Sciences Times - 0
Biotech

Virginia Bio Will Direct New “Virginia Bio-Connect” Statewide Consortium to Strengthen Competitiveness of Virginia’s Life Science Ecosystem

Life Sciences Times - 0
Biotech

A2 Biotherapeutics Enters Into Collaboration Agreement With Merck To Develop Allogeneic Cell Therapy

Life Sciences Times - 0
Biotech

Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds

Life Sciences Times - 0
Pharma

Cecilia Jones Joins LogicBio Therapeutics as Chief Financial Officer

Life Sciences Times - 0
Pharma

Servier to Acquire Cambridge-Based Agios Pharmaceuticals’ Oncology Business

Life Sciences Times - 0
1...26272829Page 27 of 29

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv